News
In myelodysplastic syndrome, improved tool for predicting death after HCT
Key clinical point: A portion of patients with myelodysplastic syndrome in high- and very high–risk groups of the revised International Prognostic...
News
OTX015 dose for lymphoma narrowed in phase 1 study
Key clinical point: For lymphoma patients, a regimen has been determined for the small-molecule inhibitor OTX015 that was associated with...
News
LMWH doesn’t reduce late pregnancy loss in women with thrombophilias
Prophylactic-dose low molecular weight heparin, with or without aspirin, did not reduce the risk of pregnancy loss in women with inherited...
News
Guidelines on asparaginase hypersensitivity and silent inactivation in ALL
The recommendations address therapeutic drug monitoring through serum asparaginase level assessment, indications for switching asparaginase...
News
HIV drug may overcome proteasome-inhibitor resistance in multiple myeloma
Key clinical point: Adding HIV protease inhibitors to established combinations of proteasome inhibitors may improve outcomes in patients with...
News
Follicular lymphoma: Quantitative PET/CT measures for detecting bone marrow involvement
Key clinical point: Measuring the mean standardized uptake value of 18fluorodeoxyglucose in the bone marrow of patients with follicular lymphoma...
News
Novel test detects low levels of residual CML
Key clinical point: A novel test may predict which CML patients in remission can safely stop TKI therapy. Major finding: Digital PCR for BCR-ABL1...
News
